| | |
|
Over the past decade, there has been a paradigm shift in the treatment of cancer, driven by advances in personalized medicine and immuno-oncology. The global oncology market is expected to continue growing at 9% between 2016 and 2021, one of the highest forecasted growth rates among ATC1s. The focus on oncology will remain high over the next decade driven by the ongoing research and development and remaining unmet need. In the Middle East too, oncology has become an area where pharma companies are investing a lot of resources and efforts; it was the 6th highest selling and the 2nd fastest growing therapy area in MAT Q3 2017.
Oncology is not one disease but hundreds of diseases. Hence our customers need as much insight as possible for the specific cancer they are targeting. We are pleased to announce that we now have a dedicated “Oncology Team” in Middle East to help our Oncology customer get those insights. This practice will integrate all our existing oncology offerings and develop new ones to address specific needs of the Oncology business stakeholders in the region. As a start, we would like to present our view of the oncology market in the Middle East, needs of the oncology Pharma customer and IQVIA as a partner to support customers, such as you, on their oncology journey. Please click here to download and read the presentation.
Key Highlights from the presentation
The Middle East oncology pharmaceutical market is valued at ~ $ 556 Mn driven by growth in value of targeted therapies which constitute 73% of total sales. Oncology growth, in the past 4 years, has been propelled by new launch targeted therapies and this swift uptake of newly launched products reflects the innovation rewarding nature of Middle East oncology.
But even with such encouraging figures, there exist innate gaps on the cancer care pathway in Middle East and the changing oncology access. Stakeholders and their needs demand enhanced value communication at each milestone. Hence, IQVIA has identified three key areas to support Oncology companies aiming to excel in the Middle East environment – “Oncology Analytics” (grounded in patient data), “Product Launch Suite of Services” (to ensure successful uptake and access) and “Care Continuum/Disease Area Leadership Endeavors” (to address gaps on the care pathway with innovative solutions).
Please feel free to contact Snehanshu (Snehanshu.S@iqvia.com) or Tamer Ali (Tamer.Ali@iqvia.com) in case you have any queries about the presentation or would like to discuss your oncology needs over a meeting.
|
| |
|
|
